The Nuclear Function of IL-33 in Desensitization to DNA Damaging Agent and Change of Glioma Nuclear Structure

The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation

(2020) Lin Lin et al.   Aging-US

Immunotherapy for glioma: Current management and future application

(2020) Shengchao Xu et al.   CANCER LETTERS

Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression

(2020) Astrid De Boeck et al.   Nature Communications

Down‐regulation of interleukin‐33 expression in oligodendrocyte precursor cells impairs oligodendrocyte lineage progression

(2019) Hsin‐Yu Sung et al.   JOURNAL OF NEUROCHEMISTRY

IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C

(2019) Jian-fei Zhang et al.   Scientific Reports

High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression

(2018) Riccardo Sgarra et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

A network map of IL-33 signaling pathway

(2018) Sneha M. Pinto et al.   Journal of Cell Communication and Signaling

Primary brain tumours in adults

(2018) Sarah Lapointe et al.   LANCET

Chromatin regulates IL-33 release and extracellular cytokine activity

(2018) Jared Travers et al.   Nature Communications

Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family

(2017) Corinne Cayrol et al.   IMMUNOLOGICAL REVIEWS

Functional Role of Matrix gla Protein in Glioma Cell Migration

(2017) Mu-Hui Fu et al.   MOLECULAR NEUROBIOLOGY

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

(2017) Quinn T Ostrom et al.   NEURO-ONCOLOGY

IL-33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway

(2017) Jian-Fei Zhang et al.   ONCOLOGY REPORTS

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice

(2017) C Carlock et al.   Translational Psychiatry

Potential Therapeutic Aspects of Alarmin Cytokine Interleukin 33 or Its Inhibitors in Various Diseases

(2016) Muhammad Imran Arshad et al.   CLINICAL THERAPEUTICS

Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma

(2016) Jianfei Zhang et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

The DNA fibre technique – tracking helicases at work

(2016) Jadwiga Nieminuszczy et al.   METHODS

Interleukin 33 is a guardian of barriers and a local alarmin

(2016) Nikolas T Martin et al.   NATURE IMMUNOLOGY

Interleukin-33 in human gliomas: Expression and prognostic significance

(2016) DOROTHEE GRAMATZKI et al.   Oncology Letters

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

(2015) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide

(2015) Kit Man Chai et al.   Oncotarget

Implications for Interleukin-33 in solid organ transplantation

(2013) Quan Liu et al.   CYTOKINE

Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells

(2013) Kuan-Min Fang et al.   NEURO-ONCOLOGY

Special aspects of interleukin-33 and the IL-33 receptor complex

(2013) Michael U. Martin   SEMINARS IN IMMUNOLOGY

Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation

(2009) Shafaqat Ali et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases

(2009) Alexander U. Lüthi et al.   IMMUNITY

Interleukin-33 – cytokine of dual function or novel alarmin?

(2009) Guttorm Haraldsen et al.   TRENDS IN IMMUNOLOGY

Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation

(2008) Axel M. Küchler et al.   AMERICAN JOURNAL OF PATHOLOGY

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket

(2008) Lucie Roussel et al.   EMBO REPORTS